Metrics Expands with Fast-Track Development Laboratory - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Metrics Expands with Fast-Track Development Laboratory


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 3

Metrics is opening a new laboratory to better support fast-track development of pharmaceutical products in Greenville, NC. The new $1.6 million, 4,524 ft2 facility provides additional flexibility for early formulation and analytical method development. The facility is designed for preclinical development of early formulation prototypes and related analytical methods. In this laboratory setting, formulators and chemists will have significant autonomy to conduct development activities more quickly, according to the company.

The new processing suites will have independent HVAC systems and engineering controls such as interlocking airlock doors, room air pressure differentials, high-volume room air turnover, and 100% HEPA air filtration.The ground floor of the new facility consists of five processing rooms and one analytical laboratory. The second floor consists of workstations, office space, and a conference room. The new facility was expected to be fully operational by mid-February.

Source: Metrics

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here